Cushman Total Liab vs Long Term Debt Analysis

CWK Stock

USD 11.65 0.27 2.37%

Cushman Wakefield financial indicator trend analysis is way more than just evaluating Cushman Wakefield plc prevailing accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Cushman Wakefield plc is a good investment. Please check the relationship between Cushman Wakefield Total Liab and its Long Term Debt accounts. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

Total Liab vs Long Term Debt

Total Liab vs Long Term Debt Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Cushman Wakefield plc Total Liab account and Long Term Debt. At this time, the significance of the direction appears to have almost identical trend.

The correlation between Cushman Wakefield's Total Liab and Long Term Debt is 0.93. Overlapping area represents the amount of variation of Total Liab that can explain the historical movement of Long Term Debt in the same time period over historical financial statements of Cushman Wakefield plc, assuming nothing else is changed. The correlation between historical values of Cushman Wakefield's Total Liab and Long Term Debt is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Total Liab of Cushman Wakefield plc are associated (or correlated) with its Long Term Debt. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Long Term Debt has no effect on the direction of Total Liab i.e., Cushman Wakefield's Total Liab and Long Term Debt go up and down completely randomly.

Correlation Coefficient

0.93

Relationship Direction	Positive
Relationship Strength	Very Strong

View All Relationships

Total Liab

The total amount of all liabilities that a company has, including both short-term and long-term liabilities.

Long Term Debt

Long-term debt is a debt that Cushman Wakefield plc has held for over one year. Long-term debt appears on Cushman Wakefield plc balance sheet and also includes long-term leases. The most common forms of long term debt are bonds payable, long-term notes payable, mortgage payable, pension liabilities, and lease liabilities. In the corporate world, long-term debt is generally used to fund big-ticket items, such as machinery, buildings, and land. The total of long-term debt reported on Cushman Wakefield plc balance sheet is the sum of the balances of all categories of long-term debt. Debt that is not due within the current year and is often considered to be financing activities that are to be repaid over several years.

Most indicators from Cushman Wakefield's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Cushman Wakefield plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

At this time, Cushman Wakefield's Selling General Administrative is quite stable compared to the past year. Sales General And Administrative To Revenue is expected to rise to 0.17 this year, although the value of Tax Provision will most likely fall to about 5.1 M.

	2021	2022	2023	2024 (projected)
Depreciation And Amortization	365.3M	266.9M	243.4M	326.7M
Interest Income	158.3M	108.1M	97.3M	126.3M

Depreciation And Amortization Interest Income

Cushman Wakefield fundamental ratios Correlations

	Common Stock Shares Outstanding	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Property Plant And Equipment Net	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Cash	Non Current Assets Total	Non Currrent Assets Other	Other Assets	Long Term Debt	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Total Equity	Short Term Investments	Long Term Debt Total	Non Current Liabilities Total	Capital Surpluse
Common Stock Shares Outstanding		0.94	0.95	0.21	0.89	0.82	-0.82	0.74	0.94	0.51	0.83	-0.58	0.87	0.69	0.93	0.94	0.67	0.83	0.69	0.82	0.94	-0.82	0.82	0.81	0.83	0.82
Total Assets	0.94		0.95	0.45	0.96	0.95	-0.92	0.82	0.95	0.24	0.74	-0.66	0.96	0.81	0.95	0.97	0.74	0.87	0.81	0.91	0.97	-0.94	0.93	0.84	0.75	0.94
Short Long Term Debt Total	0.95	0.95		0.28	0.88	0.81	-0.82	0.74	0.9	0.4	0.86	-0.66	0.86	0.75	0.94	0.95	0.71	0.96	0.75	0.8	0.97	-0.83	0.84	0.9	0.89	0.84
Other Current Liab	0.21	0.45	0.28		0.46	0.6	-0.52	0.49	0.45	-0.47	0.11	-0.28	0.55	0.38	0.37	0.45	0.44	0.32	0.38	0.52	0.36	-0.52	0.53	0.23	0.03	0.52
Total Current Liabilities	0.89	0.96	0.88	0.46		0.92	-0.98	0.78	0.94	0.23	0.67	-0.68	0.97	0.77	0.89	0.92	0.68	0.78	0.77	0.91	0.95	-0.92	0.93	0.77	0.6	0.92
Total Stockholder Equity	0.82	0.95	0.81	0.6	0.92		-0.92	0.83	0.9	0.03	0.56	-0.6	0.97	0.79	0.86	0.9	0.77	0.72	0.79	0.93	0.88	-0.95	0.96	0.76	0.53	0.97
Other Liab	-0.82	-0.92	-0.82	-0.52	-0.98	-0.92		-0.76	-0.93	-0.12	-0.58	0.72	-0.97	-0.79	-0.82	-0.86	-0.65	-0.72	-0.79	-0.86	-0.92	0.91	-0.95	-0.74	-0.49	-0.92
Net Tangible Assets	0.74	0.82	0.74	0.49	0.78	0.83	-0.76		0.8	0.15	0.67	-0.25	0.78	0.51	0.84	0.77	0.84	0.72	0.51	0.89	0.77	-0.72	0.72	0.79	0.53	0.72
Property Plant And Equipment Net	0.94	0.95	0.9	0.45	0.94	0.9	-0.93	0.8		0.29	0.7	-0.65	0.95	0.77	0.89	0.92	0.7	0.77	0.77	0.85	0.95	-0.9	0.91	0.78	0.67	0.91
Current Deferred Revenue	0.51	0.24	0.4	-0.47	0.23	0.03	-0.12	0.15	0.29		0.72	0.13	0.06	-0.18	0.45	0.36	0.3	0.33	-0.18	0.26	0.27	0.05	0.04	0.37	0.49	-0.02
Net Debt	0.83	0.74	0.86	0.11	0.67	0.56	-0.58	0.67	0.7	0.72		-0.24	0.57	0.31	0.9	0.83	0.74	0.87	0.31	0.72	0.74	-0.48	0.53	0.83	0.84	0.49
Retained Earnings	-0.58	-0.66	-0.66	-0.28	-0.68	-0.6	0.72	-0.25	-0.65	0.13	-0.24		-0.74	-0.92	-0.45	-0.58	-0.14	-0.58	-0.92	-0.36	-0.75	0.79	-0.75	-0.47	-0.5	-0.77
Accounts Payable	0.87	0.96	0.86	0.55	0.97	0.97	-0.97	0.78	0.95	0.06	0.57	-0.74		0.87	0.85	0.9	0.65	0.75	0.87	0.87	0.94	-0.98	0.97	0.74	0.59	0.98
Cash	0.69	0.81	0.75	0.38	0.77	0.79	-0.79	0.51	0.77	-0.18	0.31	-0.92	0.87		0.6	0.7	0.37	0.66	1.0	0.56	0.84	-0.93	0.87	0.61	0.57	0.92
Non Current Assets Total	0.93	0.95	0.94	0.37	0.89	0.86	-0.82	0.84	0.89	0.45	0.9	-0.45	0.85	0.6		0.97	0.83	0.91	0.6	0.93	0.91	-0.79	0.81	0.88	0.8	0.8
Non Currrent Assets Other	0.94	0.97	0.95	0.45	0.92	0.9	-0.86	0.77	0.92	0.36	0.83	-0.58	0.9	0.7	0.97		0.77	0.89	0.7	0.9	0.93	-0.86	0.88	0.83	0.79	0.87
Other Assets	0.67	0.74	0.71	0.44	0.68	0.77	-0.65	0.84	0.7	0.3	0.74	-0.14	0.65	0.37	0.83	0.77		0.71	0.37	0.86	0.65	-0.59	0.7	0.87	0.48	0.65
Long Term Debt	0.83	0.87	0.96	0.32	0.78	0.72	-0.72	0.72	0.77	0.33	0.87	-0.58	0.75	0.66	0.91	0.89	0.71		0.66	0.74	0.9	-0.73	0.73	0.9	0.89	0.72
Cash And Short Term Investments	0.69	0.81	0.75	0.38	0.77	0.79	-0.79	0.51	0.77	-0.18	0.31	-0.92	0.87	1.0	0.6	0.7	0.37	0.66		0.56	0.84	-0.93	0.87	0.61	0.57	0.92
Net Receivables	0.82	0.91	0.8	0.52	0.91	0.93	-0.86	0.89	0.85	0.26	0.72	-0.36	0.87	0.56	0.93	0.9	0.86	0.74	0.56		0.82	-0.81	0.84	0.78	0.54	0.82
Good Will	0.94	0.97	0.97	0.36	0.95	0.88	-0.92	0.77	0.95	0.27	0.74	-0.75	0.94	0.84	0.91	0.93	0.65	0.9	0.84	0.82		-0.92	0.91	0.85	0.78	0.91
Common Stock Total Equity	-0.82	-0.94	-0.83	-0.52	-0.92	-0.95	0.91	-0.72	-0.9	0.05	-0.48	0.79	-0.98	-0.93	-0.79	-0.86	-0.59	-0.73	-0.93	-0.81	-0.92		-0.96	-0.7	-0.6	-0.99
Short Term Investments	0.82	0.93	0.84	0.53	0.93	0.96	-0.95	0.72	0.91	0.04	0.53	-0.75	0.97	0.87	0.81	0.88	0.7	0.73	0.87	0.84	0.91	-0.96		0.78	0.54	0.99
Long Term Debt Total	0.81	0.84	0.9	0.23	0.77	0.76	-0.74	0.79	0.78	0.37	0.83	-0.47	0.74	0.61	0.88	0.83	0.87	0.9	0.61	0.78	0.85	-0.7	0.78		0.74	0.74
Non Current Liabilities Total	0.83	0.75	0.89	0.03	0.6	0.53	-0.49	0.53	0.67	0.49	0.84	-0.5	0.59	0.57	0.8	0.79	0.48	0.89	0.57	0.54	0.78	-0.6	0.54	0.74		0.57
Capital Surpluse	0.82	0.94	0.84	0.52	0.92	0.97	-0.92	0.72	0.91	-0.02	0.49	-0.77	0.98	0.92	0.8	0.87	0.65	0.72	0.92	0.82	0.91	-0.99	0.99	0.74	0.57

Click cells to compare fundamentals

Cushman Wakefield Account Relationship Matchups

Cushman Wakefield fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Common Stock Shares Outstanding	224.5M	220.8M	226.5M	228M	226.9M	224.9M
Total Assets	7.2B	7.3B	7.9B	7.9B	7.8B	7.7B
Short Long Term Debt Total	3.1B	3.7B	3.7B	3.6B	3.6B	3.5B
Other Current Liab	189.6M	205.8M	204.5M	1.1B	217.6M	206.7M
Total Current Liabilities	2.3B	2.1B	2.4B	2.4B	2.4B	2.4B
Total Stockholder Equity	1.3B	1.1B	1.4B	1.7B	1.7B	1.3B
Other Liab	364.4M	535.5M	392.2M	339.8M	305.8M	399.2M
Net Tangible Assets	(1.7B)	(2.0B)	(1.6B)	786.8M	904.8M	950.1M
Property Plant And Equipment Net	490.7M	438.2M	413.5M	530.6M	500.6M	445.1M
Current Deferred Revenue	948.4M	765.6M	1.1B	872.2M	1.0B	851.0M
Net Debt	2.3B	2.6B	2.9B	3.0B	2.8B	2.8B
Retained Earnings	(1.3B)	(1.5B)	(1.3B)	(1.1B)	(1.1B)	(1.2B)
Accounts Payable	1.1B	1.1B	1.1B	1.2B	1.2B	1.1B
Cash	813.2M	1.1B	770.7M	644.5M	767.7M	791.2M
Non Current Assets Total	4.3B	4.4B	5.1B	5.2B	5.0B	4.9B
Non Currrent Assets Other	685.7M	743.5M	935.7M	976M	805.8M	754.3M
Other Assets	453.6M	569M	806.6M	1.0B	1.2B	693.8M
Long Term Debt	2.6B	3.2B	3.2B	3.2B	3.1B	3.2B
Cash And Short Term Investments	813.2M	1.1B	770.7M	644.5M	767.7M	791.2M
Net Receivables	1.6B	1.3B	1.8B	1.9B	1.8B	1.7B
Good Will	2.0B	2.1B	2.1B	2.1B	2.1B	2.1B
Common Stock Total Equity	22M	22.2M	22.4M	22.6M	20.3M	19.3M
Long Term Debt Total	2.6B	3.2B	3.2B	3.2B	3.7B	3.2B
Liabilities And Stockholders Equity	7.2B	7.3B	7.9B	7.9B	7.8B	7.7B
Non Current Liabilities Total	3.5B	4.2B	4.0B	3.9B	3.7B	4.0B
Capital Surpluse	2.8B	2.8B	2.9B	2.9B	3.3B	2.3B
Other Current Assets	484.4M	470.8M	264.7M	246.3M	189.4M	318.5M
Other Stockholder Equity	2.8B	2.8B	2.9B	2.9B	2.8B	2.4B
Total Liab	5.9B	6.2B	6.4B	6.3B	6.1B	6.4B
Short Long Term Debt	39.3M	39.7M	42.4M	49.8M	149.7M	157.2M
Total Current Assets	2.9B	2.9B	2.8B	2.8B	2.8B	2.8B
Accumulated Other Comprehensive Income	(242.8M)	(242.7M)	(193M)	(191M)	(185.4M)	(194.7M)
Non Current Liabilities Other	352.1M	838.9M	738.1M	293.3M	268.6M	368.5M
Cash And Equivalents	813.2M	1.1B	770.7M	644.5M	741.2M	783.6M
Short Term Debt	39.3M	39.7M	42.4M	49.8M	149.7M	157.2M
Intangible Assets	1.1B	991.2M	922.2M	874.5M	808.1M	851.0M
Common Stock	22M	22.2M	22.4M	22.6M	22.7M	21.6M

Becoming a Better Investor with Macroaxis

Macroaxis puts the power of mathematics on your side. We analyze your portfolios and positions such as Cushman Wakefield plc using complex mathematical models and algorithms, but make them easy to understand. There is no real person involved in your portfolio analysis. We perform a number of calculations to compute absolute and relative portfolio volatility, correlation between your assets, value at risk, expected return as well as over 100 different fundamental and technical indicators.

Build Optimal Portfolios

Align your risk with return expectations

By capturing your risk tolerance and investment horizon Macroaxis technology of instant portfolio optimization will compute exactly how much risk is acceptable for your desired return expectations

Fix portfolios for free

When determining whether Cushman Wakefield plc is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Cushman Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Cushman Wakefield Plc Stock. Highlighted below are key reports to facilitate an investment decision about Cushman Wakefield Plc Stock:

How To Invest In Cushman

Details

Is Cushman Stock a good investment?

Details

What is Cushman Wakefield's Net Worth?

Details

Largest Real Estate Management & Development Companies

View

Largest Real Estate Companies

View

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Cushman Wakefield plc. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in housing.

You can also try the Price Transformation module to use Price Transformation models to analyze the depth of different equity instruments across global markets.

Complementary Tools for Cushman Stock analysis

When running Cushman Wakefield's price analysis, check to measure Cushman Wakefield's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cushman Wakefield is operating at the current time. Most of Cushman Wakefield's value examination focuses on studying past and present price action to predict the probability of Cushman Wakefield's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cushman Wakefield's price. Additionally, you may evaluate how the addition of Cushman Wakefield to your portfolios can decrease your overall portfolio volatility.

	Portfolio Rebalancing Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
	Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios
	Transaction History View history of all your transactions and understand their impact on performance
	Companies Directory Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
	Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings
	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Commodity Channel Use Commodity Channel Index to analyze current equity momentum
	CEOs Directory Screen CEOs from public companies around the world
	USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA
	ETFs Find actively traded Exchange Traded Funds (ETF) from around the world
	AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities

Is Cushman Wakefield's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Cushman Wakefield. If investors know Cushman will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Cushman Wakefield listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

1.289

Earnings Share

0.05

Revenue Per Share

41.479

Quarterly Revenue Growth

(0.03)

Return On Assets

0.0239

The market value of Cushman Wakefield plc is measured differently than its book value, which is the value of Cushman that is recorded on the company's balance sheet. Investors also form their own opinion of Cushman Wakefield's value that differs from its market value or its book value, called intrinsic value, which is Cushman Wakefield's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Cushman Wakefield's market value can be influenced by many factors that don't directly affect Cushman Wakefield's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Cushman Wakefield's value and its price as these two are different measures arrived at by different means. Investors typically determine if Cushman Wakefield is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Cushman Wakefield's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Cushman Total Liab vs Long Term Debt Analysis

Total Liab vs Long Term Debt

Total Liab vs Long Term Debt Correlation Analysis

Correlation Coefficient

Total Liab

Long Term Debt

Cushman Wakefield fundamental ratios Correlations

Cushman Wakefield Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Cushman Wakefield fundamental ratios Accounts

Becoming a Better Investor with Macroaxis

Build Optimal Portfolios

Align your risk with return expectations

Complementary Tools for Cushman Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Cash
Capital Surpluse	+ 0.99	Short Term Investments
Capital Surpluse	+ 0.98	Accounts Payable
Non Currrent Assets Other	+ 0.97	Total Assets
Good Will	+ 0.97	Total Assets
Good Will	+ 0.97	Short Long Term Debt Total

Capital Surpluse	- 0.99	Common Stock Total Equity
Common Stock Total Equity	- 0.98	Accounts Payable
Other Liab	- 0.98	Total Current Liabilities
Accounts Payable	- 0.97	Other Liab
Short Term Investments	- 0.96	Common Stock Total Equity
Short Term Investments	- 0.95	Other Liab